Over 10 years of experience in leading IND-enabling studies of gene therapy (AAV, lentivirus, ZFN, CRISPR, gene regulation), resulting in 2 IND approvals, 6 pending patents, 23 manuscripts, 62 abstracts, and 23 oral presentations. Contributed to organizing international academic conferences, ASGCT and WORLD Symposium.
Vice President at Genemagic Biosciences
Ph.D., Genetics (Major), Biostatistics (Minor)